As of 27-Apr-2020 the current ad-hoc reference period eRMRs will no longer be available for EVDAS. These reports will be replaced by different fixed reference period eRMRs that will cover fixed periods of 15 days, 1 month, 3 months, 6 months and 1 year. The new fixed...
Our Pharmacovigilance Director will be attending the 8th Annual Pharmacovigilance Forum to be held in Bratislava next week within the ‘Future of Healt Summit’ , where relevant experts and speakers from both EU and non-EU Pharma companies will be discussing new...
Eignapharma participate in the upcoming CPhI South East Asia scheduled to take place in Bangkok, Thailand from March 12thto 14th 2019. We look forward to making new friends and entertaining profitable meetings.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.